Takeda
650 East Kendall Street
Cambridge
MA
02421
United States
Website: https://www.takeda.com/
Email: info@takeda.com
About Takeda
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.
For more information, visit https://www.takeda.com.
Stock Symbol: TAK
Science is the foundation for everything we do at Takeda. We connect to our 240- year history and our strong values through our pursuit of life-transforming science where we embrace a culture of collaboration, pursue modalities based on validated targets, evaluate real-world impact and generate data that may enable accelerated development and regulatory pathways.
1433 articles with Takeda
-
Evotec Reaches First Milestone And Receives Success Payment In Alzheimer's Disease Collaboration With Takeda Pharmaceutical Co. Ltd.
12/6/2005
-
Takeda Pharmaceuticals North America, Inc. Names Chief Compliance Officer
11/22/2005
-
New Data Shows Eli Lilly and Company's ACTOS(R) (pioglitazone HCl) Reduced Heart Attacks By 28 Percent In People With Type 2 Diabetes
11/16/2005
-
Takeda Pharmaceuticals North America, Inc. Release: ACTOplus Met(TM) (Pioglitazone HCl And Metformin HCl) Now Available In U.S. Pharmacies
11/1/2005
-
FDA Approved Takeda Pharmaceuticals North America, Inc.'s ROZEREM(TM), First And Only Non-Scheduled Prescription Sleep Medication
7/25/2005
-
Merger Mania Besets Japanese Pharmaceuticals
2/23/2005
-
Drug Companies Launch New Discount Card
1/12/2005
-
The United States District Court For The District Of Massachusetts Release: Court To Notify Those Who Paid For Prescription Drug Lupron(R), As A Result Of A Nationwide Class Action Lawsuit Settlement
1/7/2005
-
Takeda Q1 Profit Up, Keeps Flat Year Forecast
7/30/2004
-
Australia-Based Norwood Seeks IPO On London's AIM Exchange
4/7/2004
-
New Drug Researched For War On Diabetes
2/11/2004
-
$150,000 To Prevent An Ulcer Death
12/15/2003
-
Big Pharma CEOs Gather At The Third Annual Pharmaceuticals Roundtable Hosted By Economist Conferences
11/14/2003